Clinical Trial Update: Bioactive Glass and Platelet Rich Fibrin in Intrabony Defects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating bioactive glass and platelet-rich fibrin for intrabony defects in periodontal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontal Diseases

Snippet

Sponsor: Dr. D. Y. Patil Dental College & Hospital | Conditions: Periodontal Diseases, Bone Resorption | Phase 3 | Status: COMPLETED